Prevalence of Tapia's Syndrome in Weaning Unit

Study acronym: PRESTIO
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 5 months later Nov 7, 2025 → Apr 7, 2027
See other at-risk trials from Hopital Forcilles

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Nov 7, 2025 to Apr 7, 2027 Show 7 more changesShow less
    • Primary endpoints: details revised at 1 of 1 entry
    • Study completion pushed from Apr 7, 2027 to Nov 7, 2027
    • Interventions: Diagnosis of Tapia's Syndrome (Diagnostic Test) to Diagnosis of Tapia's Syndrome (Diagnostic Test)
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 4 of 7 entries
    • Publications: details revised at 5 of 5 entries
    • Study description expanded, about 3 words
  2. Primary completion date: Apr 7, 2025 to Nov 7, 2025
    • Trial status: Enrolling by Invitation to Recruiting
    • Study completion date: Apr 7, 2025 to Apr 7, 2027
    • Site details revised
    v3
  3. Secondary endpoints: details revised at 1 of 7 entriesv2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tapia syndrome is a rare and poorly understood pathology. It is defined by a concomitant attack of the recurrent (branch of X) and hypoglossal (XII) nerves of peripheral or central origin. It is characterized by the paralysis of a vocal cord and the ipsilateral half of tongue. This damage is most often unilateral but it can also be bilateral. It results in dysphonia and swallowing disorders. Tapia syndrome is a rare and poorly understood pathology. To date, less than 100 cases have been described in the literature. Previous works are mainly case reports and literature reviews. No prevalence study has been performed to date. Furthermore, disagreements persist regarding the semiology. Indeed, the involvement of the soft palate is not always described.
Trial Details
NCT Number NCT06033144
Lead Sponsor Hopital Forcilles
Conditions
(from sponsor)		 Tapia's Syndrome
Enrollment 247 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov